Trial intelligence / Profile preview

Response to Bambuterol in Eosinophilic Bronchitis vs Cough Variant Asthma

NCT02002754Phase 4Unknown

Sponsor
The First Affiliated Hospital of Guangzhou Medical University
Start
Jun 2012
Primary completion
Mar 2014
Modality
Prodrugs/Conditional Activator Small Molecules
Countries
1
01

Overview

A Phase 4 trial of bambuterol in eosinophilic bronchitis (EB), cough variant asthma (CVA), sponsored by The First Affiliated Hospital of Guangzhou Medical University. Status: unknown.

02

Drugs

bambuterol
03

Conditions

eosinophilic bronchitis (EB)cough variant asthma (CVA)

Beyond the preview

Go deeper on NCT02002754.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02002754.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call